Clinical Briefings™: Identifying Risk Factors and Improving Quality of Life in Dry Eye Disease

Released On
February 12, 2020

Expires On
February 12, 2021

Media Type
Internet

Completion Time
60 minutes

Specialty
Ophthalmology, Primary Care

 

Scroll to the Bottom of this Information to Begin this Course

This activity is provided by Physicians’ Education Resource®, LLC..

 

Supported by an educational grant from Alcon and Novartis Pharmaceuticals Corporation.

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)
  • Nurses — maximum of 1.0 contact hour.

All other health care professionals completing this course will be issued a statement of participation.

Target Audience

This online educational activity is directed toward ophthalmologists and other health care professionals involved in dry eye disease care, such as PCPs, NPs and PAs.

Program Overview

Dry eye disease (DED) is a common condition in the general public, with particular prevalence among patients who wear contact lenses and those seeking treatment for cataracts. A variety of screening and diagnostic tools are available for eye care professionals to identify DED, and a range of over-the-counter treatments, prescription medications, and devices have demonstrated therapeutic efficacy. This educational program provides a high-level overview of recent guidelines covering DED diagnosis and treatment for general populations and preoperative patients, as well as expert perspective focusing on particular topics of interest for eye care professionals, such as choosing efficient point-of-care tests; evaluating patients for aqueous deficient, evaporative, and mixed features; and identifying ocular “masqueraders” that mimic DED.

Learning Objectives

Upon successful completion of this educational activity, you should be better prepared to:

  • Review risk factors associated with dry eye disease and their role in screening and early diagnosis in affected patients
  • Evaluate clinical efficacy and safety data for current and emerging therapies for patients with dry eye
  • Develop an individualized management plan to overcome patient barriers to care

Faculty

Terry Kim, MD

Professor of Ophthalmology
Duke University School of Medicine
Chief, Cornea and External Disease Division
Director, Refractive Surgery Service
Vice-President/President-Elect, American Society of Cataract and Refractive Surgery (ASCRS)
Duke University Eye Center
Durham, NC

Accreditation Statement

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hour.

Disclosures of Conflicts of Interest

Terry Kim, MD

  • Consultant: Aerie Pharmaceuticals, Alcon, Allergan, Avedro, Avellino Labs, Bausch & Lomb, BlephEx, CorneaGen, Dompé, Eyenovia, Johnson & Johnson, Kala Pharmaceuticals, NovaBay Pharmaceuticals, Novartis, Ocular Therapeutix, Omeros, Presbyopia Therapies, Shire, Sight Sciences, Simple Contacts, Surface, Zeiss; Stock/Shareholder: Avellino Labs, CorneaGen, Eyenovia, Kala Pharmaceuticals, NovaBay Pharmaceuticals, Ocular Therapeutix, Omeros, Presbyopia Therapies, Simple Contacts

The staff of Physicians' Education Resource®, LLC (PER®) have no relevant financial relationships with commercial interests to disclose.

Disclosure of Unlabeled Use

This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent clinical judgment of a physician relative to diagnostic or treatment options for a specific patient’s medical condition.

The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or the company that provided commercial support.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI.

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Instructions for Participation and Credit

  • You will need to log in to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review video files/content until you finish the presentation.
  • At the end of the activity, “Educational Content/Videos” will be available for your reference.
  • In order to receive a CME Certificate, you must complete the activity.
  • Complete the Posttest and the Evaluation, and then click on “Request for Credit.” You may immediately download a CME Certificate upon completion of these steps.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above.